12 completed, 2 unknown, 1 terminated. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Completed 12, Unknown 2, Terminated 1 |
Follow Obsessive Compulsive Disorder: new trials by email Literature Review of Obsessive Compulsive Disorder trials Research Report on Obsessive Compulsive Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder Fluvoxamine+Methylphenidate hydrochloride, Fluvoxamine+sugar pill - Obsessive Compulsive Disorder | Phase 4 | Completed | Guangdong Provincial People's Hospital | 60 | 2013-10-01 | 2015-10-23 |
| Deep Brain Stimulation for Obsessive Compulsive Disorder (OCD PMCF) Reclaim® Deep Brain Stimulation - Obsessive Compulsive Disorder | Phase 4 | Completed | MedtronicNeuro | 32 | 2010-04-01 | 2018-01-23 |
| Ondansetron Augmentation in Treatment-resistant OCD Ondansetron - Obsessive Compulsive Disorder | Phase 4 | Completed | Institute of Neuroscience, Florence, Italy | 21 | 2009-12-01 | 2011-02-24 |
| Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD) Luvox CR, Behavioral Therapy - Obsessive Compulsive Disorder | Phase 4 | Unknown | Rogers Center for Research & Training, Inc. | 50 | 2008-09-01 | 2008-09-04 |
| Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder escitalopram - Obsessive Compulsive Disorder | Phase 4 | Completed | Seoul National University Hospital | 176 | 2008-09-01 | 2011-08-08 |
| Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD) ondansetron - Obsessive Compulsive Disorder | Phase 4 | Completed | Institute of Neuroscience, Florence, Italy | 14 | 2008-03-01 | 2011-02-24 |
| Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment Clomipramine (fluoxetine plus clomipramine), Quetiapine (fluoxetine plus quetiapine), Placebo (fluoxetine plus placebo) - Obsessive Compulsive Disorder | Phase 4 | Completed | University of Sao Paulo | 54 | 2007-05-01 | 2017-10-30 |
| Treatment Youth With Obsessive-Compulsive Disorder Escitalopram - Obsessive Compulsive Disorder | Phase 4 | Unknown | University of Ottawa | 40 | 2007-01-01 | 2008-07-02 |
| Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents Fluvoxamine maleate, Placebo - Obsessive Compulsive Disorder | Phase 4 | Terminated | Solvay Pharmaceuticals | 20 | 2006-08-01 | 2010-03-04 |
| Group Cognitive Behavioral Therapy Versus Fluoxetine for Obsessive-Compulsive Disorder: a Practical Trial Group Cognitive Behavior Therapy, SSRI (fluoxetine, sertraline, paroxetine, citalopram) - Obsessive Compulsive Disorder | Phase 4 | Completed | University of Sao Paulo | 158 | 2006-01-01 | 2009-02-16 |
| Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-compulsive Disorder Patients Quetiapine, Clomipramine - Obsessive Compulsive Disorder | Phase 4 | Completed | University of Sao Paulo | 21 | 2006-01-01 | 2017-10-27 |
| Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD) Duloxetine - Obsessive Compulsive Disorder | Phase 4 | Completed | Massachusetts General Hospital | 20 | 2005-12-01 | 2019-03-19 |
| Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD) Escitalopram - Obsessive Compulsive Disorder | Phase 4 | Completed | Massachusetts General Hospital | 30 | 2002-10-01 | 2007-04-24 |
| Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD) Topiramate, placebo - Obsessive Compulsive Disorder | Phase 4 | Completed | McMaster University | 23 | 2002-01-01 | 2020-09-01 |
| Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections Amoxicillin - Autoimmune Disease, Mental Disorder | Phase 4 | Completed | National Institute of Mental Health (NIMH) | 30 | 1997-07-01 | 2008-03-04 |
Obsessive-Compulsive Disorder (15) · Autoimmune Diseases (1) · Compulsive Behavior (1) · Mental Disorders (1) · Obsessive Behavior (1) · Streptococcal Infections (1) · Tic Disorders (1)
Anxiety Disorders (15) · Mental Disorders (14) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Behavior (1) · Behavioral Symptoms (1) · Central Nervous System Diseases (1) · Gram-Positive Bacterial Infections (1) · Immune System Diseases (1) · Impulsive Behavior (1) · Infections (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurodevelopmental Disorders (1)
Escitalopram (3) · Behavior Therapy (2) · Clomipramine (2) · Dexetimide (2) · Fluoxetine (2) · Fluvoxamine (2) · Ondansetron (2) · Quetiapine Fumarate (2) · Amoxicillin (1) · Citalopram (1) · Duloxetine Hydrochloride (1) · Paroxetine (1) · Psychotherapy, Group (1) · Selective Serotonin Reuptake Inhibitors (1) · Sertraline (1)
University of Sao Paulo (3) · Institute of Neuroscience, Florence, Italy (2) · Massachusetts General Hospital (2) · Guangdong Provincial People's Hospital (1) · McMaster University (1) · MedtronicNeuro (1) · National Institute of Mental Health (NIMH) (1) · Rogers Center for Research & Training, Inc. (1) · Seoul National University Hospital (1) · Solvay Pharmaceuticals (1) · University of Ottawa (1)
United States (4) · Brazil (3) · Italy (3) · Canada (2) · Belgium (1) · China (1) · Germany (1) · Israel (1) · Japan (1) · South Korea (1) · Spain (1) · Sweden (1) · Switzerland (1)
Darin D Dougherty, MD (2) · Juliana B Diniz, MD (2) · Stefano Pallanti, MD (2) · Andreas Wahl-Kordon, MD (1) · Antonio Higueras, MD (1) · Cristina B Silva, Psychologist (1) · Diana Radu-Djurfeldt (1) · John H Greist, MD (1) · Jose M Menchon, MD (1) · Jun Soo Kwon, M.D., Ph.D. (1) · Loes Gabriels, MD PhD MsEng (1) · Ludger Tebartz van Elst, MD (1) · Martine F. Flament, MD (1) · Michael VanAmeringen, MD, FRCPC (1)
PMID 19578654, PMID 19958042, PMID 21907540, PMID 22020357, PMID 22841131, PMID 23948637, PMID 25637377
2005 (2)